ADHD isn't a lack of attention — it's a difference in how the brain manages dopamine, regulates its own "mind-wandering" network, and responds to reward. Decades of neuroscience research have mapped out what's actually going on, and none of it is about effort or willpower.
It's a chemistry balance, not a deficit
The dopamine hypothesis is the most consistent finding in ADHD neuroscience: a controlled PET imaging study using the tracer altropane found significantly higher dopamine transporter density in adults with ADHD compared to controls, concentrated in the striatum — the hub connecting the prefrontal cortex to the brain's reward and movement circuits.1 This isn't simply "too little" dopamine — it's a signalling imbalance that affects how the brain prioritises and sustains attention on tasks that aren't inherently stimulating.
It's worth being upfront that this single-mechanism version of the dopamine hypothesis is a simplification. Other PET studies using different tracers and methods have found normal or even lower dopamine transporter density in some ADHD samples, and a meta-analysis of the transporter-imaging literature found the direction of the effect depends heavily on prior stimulant medication exposure, age, and the specific brain region measured. Dopamine dysregulation is a well-replicated theme in ADHD neuroscience — a single, universal dopamine signature that shows up the same way in every person with ADHD is not.
The prefrontal cortex — and its wiring to the rest of the brain — shows up differently
Structural and functional MRI studies consistently find differences in the prefrontal cortex — the region most responsible for planning, impulse control, working memory and sustained focus — in groups of people with ADHD compared to those without. A meta-analysis pooling 55 functional MRI studies found consistent underactivation in ADHD across frontal, parietal and basal ganglia regions involved in what's called "executive function": the mental toolkit for holding a goal in mind, filtering out distractions, and inhibiting an impulsive response in favour of a better one. Reviews of the broader imaging literature have also moved away from framing ADHD as a single circuit problem, arguing instead that it reflects disrupted communication across several large-scale brain networks working together — not one broken region, but a coordination issue between several.2
These differences show up reliably at the group level in research. They are not used to diagnose ADHD in an individual; diagnosis is a clinical process based on behaviour and history, not a brain scan.
The mind-wandering network doesn't switch off properly
The brain has a "default mode network" — a set of regions, including the medial prefrontal cortex and posterior cingulate, that's active during rest and mind-wandering and normally quiets down when you switch to a focused, externally directed task. Research on adults with ADHD has found interference from this network into task-focused attention networks during sustained-attention tasks — weaker suppression that correlates with attention lapses — which may help explain why attention can drift even when someone is trying hard to concentrate.3 A large-scale "mega-analysis" combining brain-imaging data across multiple independent cohorts, published in 2022, found broadly consistent support for this default-mode disruption at a population level, while also noting the effect size in any single scan is small — useful for understanding ADHD as a group phenomenon, not for spotting it in one person's scan.
The reward system responds less to anticipation — and why that matters for daily focus
A study measuring brain activity during a reward-anticipation task found decreased ventral striatum activity while anticipating a reward in children with more ADHD symptoms, regardless of whether they had a formal ADHD diagnosis — a dose-response relationship with symptom severity, not just a yes/no diagnostic difference.4 This is consistent with what's often described clinically as an "interest-based" nervous system — one that engages readily with novel or urgent tasks but struggles to sustain effort toward a distant payoff.
This links to one of the more influential behavioural models in the field: the "delay aversion" hypothesis, formalised by researcher Edmund Sonuga-Barke in a widely cited dual-pathway framework. The idea is that some ADHD attention difficulty isn't a pure executive-function (planning/inhibition) problem at all, but a motivational one — a brain that finds waiting itself aversive, and that will do almost anything, including get distracted, to escape a delay.5 The model proposes that executive-function deficits and delay aversion are at least partially separate pathways to the same outward symptoms, which is part of why ADHD looks so different from one person to the next — one person's attention difficulty might be mostly about filtering distraction, another's mostly about tolerating boredom, and many people show some of both.
So why do stimulant medications help — and what does that tell us?
Stimulant medications like methylphenidate work, at a mechanistic level, by blocking the dopamine transporter — the same protein highlighted in the PET imaging research above — which increases the amount of dopamine available in the synapse. A brain-imaging study measuring this directly found that therapeutic doses of oral methylphenidate significantly increased extracellular dopamine levels in the human brain, and that the degree of dopamine transporter blockade correlated with the drug's behavioural effects.6 On the surface, that looks like strong confirmation of a straightforward "too little dopamine, drug adds more" story.
The reality is more nuanced, and worth stating plainly: stimulant medications also improve attention and reduce impulsivity in people who don't have ADHD, which means the medication response by itself can't be used as proof of what's different in an ADHD brain specifically. Researchers describe methylphenidate's effect as sharpening the signal-to-noise ratio in prefrontal and striatal circuits generally — making the "wanted" neural signal (the task at hand) more distinct from background "noise" (everything else competing for attention) — rather than simply correcting a single, ADHD-specific deficiency. That's a meaningful distinction: it explains why the medication works without requiring that the entire dopamine hypothesis be settled science.
It's often a developmental delay, not a permanent deficit pattern
A landmark longitudinal brain-imaging study tracked cortical thickness in over 200 children with and without ADHD and found that in ADHD, the cortex — particularly the prefrontal regions — reached peak thickness several years later than typically developing children, following the same sequence of maturation just delayed, rather than a permanently different pattern.7 That's part of why ADHD presentation can change significantly from childhood into adulthood, and why a meaningful proportion of children with ADHD see their symptoms ease as the prefrontal cortex catches up — though a large share of cases persist into adulthood in some form, which is why adult ADHD is now taken far more seriously clinically than it once was.
Where the science is still evolving
It's tempting to want one unified story — "ADHD is a dopamine problem" or "ADHD is a default-mode-network problem" — because it's tidy. The honest picture from the last two decades of imaging and genetics research is messier: ADHD appears to arise from the interaction of several partially independent brain systems (dopaminergic signalling, executive-control circuitry, default-mode regulation, and reward processing), and researchers still disagree about how much weight each system deserves and how they interact across development. Genetic research, which won't be covered in depth here, also points to ADHD being highly polygenic — influenced by many genes of small individual effect rather than one "ADHD gene" — which fits with a brain difference that shows up across multiple systems rather than one clean pathway.
What this doesn't mean
None of this research supports characterising ADHD as damage, deficiency, or a lesser brain. It's a different pattern of development and regulation, well documented at the group level, that plays out differently in every individual. The research explains why standard advice like "just focus harder" misunderstands the underlying biology — but it isn't a basis for self-diagnosis, and it doesn't replace a proper clinical assessment.
This article is for general information only and is not medical advice. Proco does not diagnose, treat, cure or prevent any condition. If you have concerns about attention, focus or ADHD, speak to a qualified healthcare professional.
References
- Spencer TJ, Biederman J, Madras BK, et al. Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane. Biological Psychiatry, 2007. pubmed.ncbi.nlm.nih.gov
- Castellanos FX, Proal E. Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends in Cognitive Sciences, 2012;16(1):17-26. pubmed.ncbi.nlm.nih.gov
- Liu L, et al. Interference of default mode on attention networks in adults with attention-deficit/hyperactivity disorder and its association with genetic variants and treatment outcomes. CNS Neuroscience & Therapeutics, 2024;30(8):e14900. pmc.ncbi.nlm.nih.gov
- Hulst RY, et al. Children with ADHD symptoms show decreased activity in ventral striatum during the anticipation of reward, irrespective of ADHD diagnosis. Journal of Child Psychology and Psychiatry, 2017. pubmed.ncbi.nlm.nih.gov
- Sonuga-Barke EJS. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biological Psychiatry, 2005;57(11):1231-1238. pubmed.ncbi.nlm.nih.gov
- Volkow ND, Wang GJ, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. The Journal of Neuroscience, 2001;21(2):RC121. pubmed.ncbi.nlm.nih.gov
- Shaw P, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences, 2007. pnas.org
Related reading
- Adult ADHD in Ireland: What the Wait Actually Looks Like
- What the Research Actually Says About Nutrition and Attention
Want to know what's actually in what you take? Join the list — no spam, just it straight.